Tetracyclines, Chloramphenicol, Erythromycin, Clindamycin, and Metronidazole

Mayo Clinic Proceedings

Volumn 66, Issue 12, 1991, Pages 1270-1280

  SMILACK, JERRY D ^a   WILSON, WALTER R ^a   COCKERILL, FRANKLIN R ^a  

^a Division of Infectious Diseases and Internal Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CHLORTETRACYCLINE; CLINDAMYCIN; DEMECLOCYCLINE; DOXYCYCLINE; ERYTHROMYCIN; METACYCLINE; METRONIDAZOLE; MINOCYCLINE; OXYTETRACYCLINE; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

BACTERIAL INFECTION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0025831139     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-6196(12)62479-3     Document Type: Article

References (55)

1. The mode of action of antibiotics on gram-negative bacilli
2. Bacterial resistance to the tetracyclines
3. Update on treatment recommendations for gonococcal infections
4. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy
5. Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Kenya
6. Sensitivity of Streptococcus pyogenes types of tetracycline and other antibiotics
7. Tetracycline-resistant pneumococci: increasing incidence and cross resistance to newer tetracyclines
8. Treatment of the acute urethral syndrome
9. Interference of iron with the absorption of tetracyclines in man
10. Antimicrobial spectrum, pharmacology, and therapeutic use of antibiotics. IV. Aminoglycosides
11. Antimicrobial agents: tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents
12. Side effects of minocycline: a double-blind study
13. Methoxyflurane, tetracycline, and renal failure
14. Tetracyclines and chloramphenicol
15. Chloramphenicol: properties and clinical use
16. Chloramphenicol: a review of its use in clinical practice
17. Antimicrobial susceptibilities of anaerobic bacteria isolated at the Mayo Clinic during 1982 through 1987: comparison with results from 1977 through 1981
18. The choice of antimicrobial drugs
19. The bacterial degradation of chloramphenicol
20. Erythromycin: a microbial and clinical perspective after 30 years of clinical use (second of two parts)
21. Campylobacter enteritis
22. Comparison of the blood levels obtained after single and multiple doses of erythromycin estolate and erythromycin stearate
23. Reversible sensorineural hearing loss with intravenous erythromycin lactobionate
24. Clindamycin: a review of fifteen years of experience
25. Erythromycin, lincomycin, and clindamycin
26. The development of antimicrobial resistance in staphylococci
27. Methicillin-resistant Staphylococcus aureus
28. Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections
29. Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation
30. Clindamycin and quinine treatment for Babesia microti infections
31. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess
32. Clindamycin vs penicillin for anaerobic lung infections: high rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus
33. Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy
34. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis (letter to the editor)
35. Drugs for parasitic infections
36. Clindamycin with primaquine for Pneumocystis carinii pneumonia
37. Clindamycin/primaquine for Pneumocystis carinii pneumonia (letter to the editor)
38. Bacterial vaginosis
39. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients
40. Clostridium difficile: clinical considerations
41. Update on pseudomembranous colitis
42. Disease associated with Clostridium difficile infection (editorial)
43. Clostridium difficile: its disease and toxins
44. Metronidazole
45. Metronidazole
46. Metronidazole
47. Susceptibility of anaerobic bacteria to 23 antimicrobial agents
48. Metronidazole in the treatment of anaerobic infections
49. Metronidazole vs clindamycin treatment of anaerobic pulmonary infection: failure of metronidazole therapy
50. Topical metronidazole for rosacea